BPC-157: A Laboratory Research Reference

BPC-157 is a synthetic peptide commonly described in the research literature as a pentadecapeptide — a peptide made up of a 15-amino-acid sequence. The abbreviation “BPC” is generally understood to stand for “body protection compound”, a non-proprietary descriptive label used in research rather than an official drug name. BPC-157 is studied in laboratory settings for its interactions with cellular repair and signalling pathways.

This page is a non-promotional scientific reference for researchers. It summarises the chemical identity, peptide sequence, molecular characteristics, laboratory research background, and analytical testing of BPC-157. It does not provide treatment, recovery, injury, or human-use recommendations of any kind. BPC-157 supplied by Bulk Aussie Peptides is for laboratory research purposes only.

Chemical Identity and Peptide Sequence

BPC-157 is a peptide whose identity is defined by its amino acid sequence. It is frequently reported as derived from a sequence found in a gastric protein, but the compound as studied is a specific, well-defined synthetic peptide of 15 amino acids. In single-letter notation it is often written as a specific 15-residue sequence; the exact sequence reproduced in a given study should be read from that study’s methods section rather than assumed from the abbreviation alone.

As a synthetic peptide, BPC-157 is assembled stepwise in the laboratory and then purified and characterised before it is supplied for research. For background on how research peptides are produced, see the synthetic peptides research guide.

Molecular Characteristics

Several molecular properties are used to identify BPC-157 in analytical documentation:

• Chain length: 15 amino acid residues, which places it in the peptide class rather than the protein class.
• Molecular weight: the theoretical molecular weight is calculated from the amino acid sequence and is reported in Daltons (Da). The measured value on a Certificate of Analysis should closely match the theoretical value.
• Physical form: supplied as a lyophilised (freeze-dried) powder, which is the standard presentation for research peptides.

Laboratory Research Background

BPC-157 has been the subject of preclinical and laboratory studies examining its behaviour in cellular and animal models. The research literature describes investigations into cellular repair processes, angiogenesis, and signalling pathways, conducted in vitro or in approved animal research models.[1] These studies are exploratory research and do not establish a therapeutic use in humans.

It is important to distinguish research findings from medical claims. BPC-157 has not been established as a safe or effective medicine, and no regulatory approval for human therapeutic use is implied by its study in the laboratory.

Analytical Testing

As with other research peptides, BPC-157 is characterised using:

• HPLC: high-performance liquid chromatography for purity assessment, reported as a percentage of total peak area.
• Mass spectrometry: for identity confirmation, by comparing the measured molecular weight against the theoretical weight derived from the sequence.

These techniques support the traceability and reproducibility of laboratory work, but they do not comment on safety in humans or suitability for any therapeutic application. Guidance on reading the resulting documents is available in the article on how to read a peptide Certificate of Analysis.

Research Terminology

Terms commonly encountered when working with BPC-157 include:

• Pentadecapeptide — a peptide of 15 amino acid residues.
• Body protection compound — the descriptive expansion of the BPC abbreviation used in research literature.
• Lyophilised powder — the freeze-dried physical form in which the peptide is supplied.

Additional general terms are defined in the research peptide glossary.

References

• [1] Sikirić, P., Petek, M., Ručman, R., & Seiwerth, S. (1993). A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. Journal of Physiology (Paris), 87(5), 313–327. PubMed 8298609.

Related Research Resources

• HPLC Peptide Testing Explained — how purity is assessed.
• Reading a Peptide Certificate of Analysis — interpreting purity and identity data.

Related Analytical Documentation

The literature above describes BPC-157 research; it is distinct from the batch-specific testing performed on any supplied material. See the Certificate of Analysis library, the batch verification tool, and the testing and quality process.